Form 4: Third Rock Ventures IV, L.P. Sells 175,000 Shares of Tango Therapeutics, Inc. (TNGX)
SEC Form 4 Filing
Third Rock Ventures IV, L.P. reports the sale of 175,000 shares of Tango Therapeutics, Inc. at an average price of $11.5983 per share.
Summary
- Third Rock Ventures IV, L.P. sold 175,000 shares of Tango Therapeutics, Inc. (TNGX) on August 30, 2024.
- The shares were sold at a weighted average price of $11.5983.
- The price range for the sales was between $11.52 and $11.90.
- Following the transaction, Third Rock Ventures IV, L.P. directly holds 17,001,475 shares of Tango Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a major shareholder. The sentiment is neutral as it simply reports a transaction.
Industry Context
Sales of shares by significant holders are a normal part of market activity. It is important to consider the context of the sale, such as the overall market conditions and the company's performance, to determine the potential impact.
Key Dates
| Date | Description |
|---|---|
| 08/30/2024 | Date of transaction: Sale of 175,000 shares of Tango Therapeutics, Inc. |
| 09/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.